Australian retail conglomerate Wesfarmers Ltd on Monday lobbed a A$680 million ($509 million) indicative bid for pharmacy chain Australian Pharmaceutical Industries (API), its first foray into the sector.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
